The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 28, 2021

Filed:

Apr. 06, 2018
Applicant:

Second Genome, Inc., South San Francisco, CA (US);

Inventors:

Andrew Wonhee Han, South San Francisco, CA (US);

Andrew Whitman Goodyear, South San Francisco, CA (US);

Tarunmeet Gujral, South San Francisco, CA (US);

Todd Zachary Desantis, South San Francisco, CA (US);

Karim Dabbagh, South San Francisco, CA (US);

Toshihiko Takeuchi, South San Francisco, CA (US);

Ye Jin, South San Francisco, CA (US);

Michi Izumi Willcoxon, South San Francisco, CA (US);

Stefanie Banas, South San Francisco, CA (US);

Assignee:

Second Genome, Inc., Brisbane, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/38 (2006.01); A61K 39/08 (2006.01); A61K 39/02 (2006.01); A61P 1/04 (2006.01); C07K 2/00 (2006.01); A61K 38/16 (2006.01); A61P 37/02 (2006.01); C07K 14/33 (2006.01); C07K 14/195 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/16 (2013.01); A61P 1/04 (2018.01); A61P 37/02 (2018.01); C07K 2/00 (2013.01); C07K 14/195 (2013.01); C07K 14/33 (2013.01); A61K 38/00 (2013.01);
Abstract

The disclosure relates to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointestinal inflammatory diseases and gastrointestinal conditions associated with decreased epithelial cell barrier function or integrity. Further, the disclosed therapeutic proteins are useful for treating human inflammatory bowel disease, including inter alia, Crohn's disease and ulcerative colitis.


Find Patent Forward Citations

Loading…